RepSox: Potent and Selective ALK5 Inhibitor for iPSC Reprogramming

Executive Summary: RepSox (CAS: 446859-33-2) is a small molecule inhibitor targeting the TGF-β type I receptor ALK5 with an IC₅₀ of 4 nM, offering high selectivity and potency in TGF-β signaling pathway inhibition (APExBIO). The compound is widely applied in induced pluripotent stem cell (iPSC) reprogramming, replacing Sox2 function via Nanog induction and facilitating efficient transformation of mouse embryonic fibroblasts (MEFs) (internal review). RepSox is soluble in DMSO and ethanol, enabling versatile use in in vitro systems. In recent studies, its combination with cytokine substitutions and megakaryocyte maturation boosters has accelerated platelet production from iPSCs while reducing costs by over 50% (Wei Yue et al., 2026). The A3754 RepSox kit from APExBIO supports research in cancer, fibrosis, and regenerative medicine by providing a validated, high-purity ALK5 inhibitor formulation.

Biological Rationale

TGF-β signaling is central to cell differentiation, proliferation, and tumor transformation. The type I receptor (ALK5/TGFβR-1) is a serine/threonine kinase that, when activated, phosphorylates Smad2/3, initiating transcriptional cascades regulating pluripotency and lineage commitment (APExBIO). Aberrant TGF-β activity has been implicated in fibrotic diseases, cancer progression, and impaired tissue regeneration (internal article). Small molecule inhibitors of ALK5, such as RepSox, offer targeted modulation of this pathway, enabling researchers to dissect TGF-β function and control cellular plasticity in vitro. By releasing repression of Id1, Id2, and Id3 genes, RepSox promotes stemness and facilitates the reprogramming of somatic cells into iPSCs. The compound's role in enhancing megakaryocyte maturation and platelet production from iPSCs further extends its utility in hematological and translational research (Wei Yue et al., 2026).

Mechanism of Action of RepSox (ALK5 inhibitor, potent and selective)

RepSox, chemically designated as 2-[5-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl]-1,5-naphthyridine (MW: 287.32), directly binds to the ATP-binding site of TGFβR-1 (ALK5), inhibiting its kinase activity with an IC₅₀ of 4 nM. This potent and selective inhibition suppresses phosphorylation of Smad2/3 proteins, blocking canonical TGF-β/Smad signaling (internal article). Downstream, RepSox releases transcriptional repression on genes such as Id1, Id2, and Id3, pivotal for maintaining pluripotency and promoting lineage reprogramming. In iPSC workflows, RepSox uniquely substitutes for Sox2 by upregulating Nanog, a core pluripotency factor, thereby enabling efficient reprogramming of MEFs alongside Oct4, Klf4, and cMyc (APExBIO). RepSox treatment also increases L-Myc expression by fivefold under typical conditions (25 μM, 3 days), further supporting reprogramming efficiency. In vivo, RepSox-induced iPSCs have demonstrated integration and function in mosaic embryos and adult mice, confirming pathway specificity and biological activity.

Evidence & Benchmarks

• RepSox inhibits TGFβR-1/ALK5 kinase with an IC₅₀ of 4 nM, as quantified in cell-free biochemical assays (APExBIO).
• RepSox treatment (25 μM, 3 days) induces Nanog and increases L-Myc expression fivefold in MEFs, enabling Sox2-independent iPSC reprogramming (internal review).
• iPSCs generated with RepSox contribute to mosaic embryos and adult mice, demonstrating in vivo pluripotency and functional reprogramming (internal article).
• Small molecule substitution (including TGF-β pathway inhibitors such as RepSox analogs) in iPSC platelet differentiation reduces cost by 58.3% and increases yield to 14.9 platelets per iPSC (Wei Yue et al., 2026).
• RepSox is insoluble in water but dissolves in DMSO (≥14.35 mg/mL) and ethanol (≥47.9 mg/mL, gentle warming); optimal storage is at -20°C (APExBIO).

For a comprehensive comparison of RepSox's molecular precision versus alternative TGF-β pathway modulators, see "RepSox (ALK5 Inhibitor): Redefining Precision in TGF-β Signaling" (this article details unique structure-activity relationships, whereas the present review focuses on protocol integration and cost-efficiency updates).

Applications, Limits & Misconceptions

RepSox is widely applied in the following research contexts:

• iPSC Reprogramming: Enables chemical induction of pluripotency in somatic cells, notably substituting for Sox2 in mouse and human systems (APExBIO).
• Megakaryocyte & Platelet Differentiation: When paired with other small molecules, RepSox accelerates megakaryocyte maturation and boosts platelet yield from iPSCs (Wei Yue et al., 2026).
• Cancer and Fibrosis Research: Serves as a tool compound for dissecting TGF-β signaling in oncology and tissue remodeling models (internal article).
• Signal Transduction Studies: Allows mechanistic studies of TGF-β/Smad pathway inhibition, downstream gene derepression, and functional consequences in vitro.

Common Pitfalls or Misconceptions

• RepSox is not suitable for diagnostic or clinical use; it is validated only for research applications (APExBIO).
• Long-term solution storage is not recommended; activity may decline due to hydrolysis or oxidation (APExBIO).
• RepSox is ineffective in water-based buffers due to poor solubility; always use DMSO or ethanol for stock solutions.
• It cannot rescue reprogramming in the absence of Oct4, Klf4, or cMyc; RepSox replaces Sox2 only (internal review).
• Excessive concentrations (>50 μM) may induce off-target cytotoxicity or stress responses in sensitive cell lines.

Workflow Integration & Parameters

RepSox (A3754) is typically used at 25 μM for 3 days in iPSC reprogramming protocols. Stocks are prepared in DMSO at ≥14.35 mg/mL or ethanol at ≥47.9 mg/mL with gentle warming. For optimal results, stocks should be aliquoted and stored at -20°C, avoiding repeated freeze-thaw cycles (APExBIO). RepSox is incorporated alongside transcription factors Oct4, Klf4, and cMyc in MEF reprogramming. In differentiation workflows, such as megakaryocyte/platelet production, RepSox is co-administered with other small molecules (e.g., blebbistatin, 740Y-P) to boost yield and maturation (Wei Yue et al., 2026).

For detailed troubleshooting, strategic integration, and extended discussion of RepSox's role in chemical reprogramming, see "RepSox (ALK5 Inhibitor): Advancing Chemical Reprogramming", which complements this article by providing protocol troubleshooting and advanced optimization strategies.

Conclusion & Outlook

RepSox remains a foundational tool for manipulating the TGF-β signaling pathway in stem cell biology, disease modeling, and regenerative medicine research. As demonstrated in cost-optimized platelet differentiation protocols, its integration with small molecule cocktails drives both efficiency and scalability (Wei Yue et al., 2026). Ongoing improvements in solubility, stability, and combinatorial protocols are expected to further expand RepSox's utility. For validated, high-purity RepSox suitable for bench research, the APExBIO A3754 kit provides a reliable choice for advanced cell biology and cancer research workflows.